PublizoomAward notice Supplies
Fourniture d’acide zolédronique, concentré de complexe prothrombinique et fibrinogène
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- HUmani SC
Charleroi - Place of performance
- 6000 Charleroi, Hainaut
not published: buyer's address - Estimated value
- €954,778 excl. VAT
- Amount awarded
- €954,778 excl. VAT
- Planned end of contract
- 3 February 2030
likely re-tender around August 2029 - Bids received
- 3
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 5 March 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le présent marché a pour objet la fourniture d'acide zolédronique inj 5mg/100ml, de concentré de complexe prothrombinique et de fibrinogène. Ces produits seront commandés pour HUmani s.c. - CHU de Charleroi-Chimay, agissant en centrale d’achat.
Awarded to
3 lots
- Acide zolédronique 5mg/100ml
- Concentré de complexe prothrombinique
- Fibrinogène
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Fourniture 'd'anastroazole, anagrelide, letrozole, bevacizumab, bortezomib et de fulvestrant 2023-2027 HUmani SC · 12 January 2024 |
Arega Pharma BV Celltrion Healthcare Netherlands BV Eurogenerics Pharmanovia Benelux B.V. |
€832,552 |
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Raamovereenkomst voor het leveren van Tocilizumab IV AZ Oudenaarde · 16 October 2026 |
Fresenius Kabi | €1,200,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
| Leveren van parenterale en inhalatie antibiotica UZ Leuven · 12 October 2026 |
sandoz Viatris Fresenius Kabi ACCORD HEALTHCARE |
€26,847,462 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 155825-2026.